Open AccessThe implementation of drug reposition for alcoholic hepatitis based on a sub-pathway integration strategy
Author(s) -
Wei Qi,
Bing Wang,
Ming Yang,
Lin Zhu,
Sen Hu,
Hui Sun
Publication year - 2020
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2020.01.36
Subject(s) - alcoholic liver disease , fatty liver , metabolic pathway , microarray , alcoholic hepatitis , drug metabolism , drug , microarray analysis techniques , enzyme , liver injury , gene , fold change , biology , gene expression , chemistry , pharmacology , biochemistry , medicine , cirrhosis , disease
To summarize, the candidate agents which are identified in the present study might give practitioners insight into the development of novel therapeutic approaches for AH.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom